[gnso-gac-closed-generics] [renamed] posting actual parts of the Framework

Patricio Poblete patricio.poblete at board.icann.org
Tue Jun 13 02:54:57 UTC 2023 

I think Kathy and Jeff are right. It is safe to assume that most people
will not have read the Framework before going to the session tomorrow.

Patricio

El lun, 12 de jun de 2023, 22:45, Kathy Kleiman <Kathy at kathykleiman.com>
escribió:

> I'm very much in favor of walking through the Framework a bit, so I concur
> with Jeff about posting actual parts of it and even reading key section
> to/with the audience.
>
> Today, in NCSG, I had a few slides.  One was the three sections of the
> Framework, and then several slides walking through the substance of each
> section. I tried to take sections that were small enough to be readable on
> screen.
>
> For example, Application Section four (specific the public interest
> goal(s)... and Section five (explain the purpose) with the details of 4a-c,
> 5a, etc. Of course, Section ten (demonstrate requirement of
> representativeness or non-anticompetitive behavior) with some of the detail.
>
> It raised the level of interest and level of discussion.
>
> Afterwards, of course, I support Manal's suggestion favoring community
> input.
>
> Best, Kathy
> On 6/12/2023 6:05 PM, Jeff Neuman wrote:
>
> I agree 100%.  I know many of them will not have read the framework, so
> lets post parts up on the screen and open the floor.
>
> Get Outlook for iOS <https://aka.ms/o0ukef>
> ------------------------------
> *From:* Sophie Hey <sophie.hey at comlaude.com> <sophie.hey at comlaude.com>
> *Sent:* Monday, June 12, 2023 5:02 PM
> *To:* Manal Ismail <manal at tra.gov.eg> <manal at tra.gov.eg>; Jeff Neuman
> <jeff at jjnsolutions.com> <jeff at jjnsolutions.com>; Mary Wong
> <mary.wong at icann.org> <mary.wong at icann.org>;
> gnso-gac-closed-generics at icann.org <gnso-gac-closed-generics at icann.org>
> <gnso-gac-closed-generics at icann.org>
> *Subject:* RE: Outline of next steps and proposed agenda for Tuesday
> session at ICANN77
>
> I support Manal's suggestion
>
> Sophie Hey
> Policy Advisor
>
> +44 (0) 20 7421 8250
> 252
>
> comlaude.com
> -----Original Message-----
> From: gnso-gac-closed-generics
> <gnso-gac-closed-generics-bounces at icann.org>
> <gnso-gac-closed-generics-bounces at icann.org> On Behalf Of Manal Ismail
> Sent: Monday, June 12, 2023 4:59 PM
> To: Jeff Neuman <jeff at jjnsolutions.com> <jeff at jjnsolutions.com>; Mary
> Wong <mary.wong at icann.org> <mary.wong at icann.org>;
> gnso-gac-closed-generics at icann.org
> Subject: Re: [gnso-gac-closed-generics] Outline of next steps and proposed
> agenda for Tuesday session at ICANN77
>
> Many thanks Patricio for the good suggestion and Melissa and Mary for
> accomodating ..
>
>
> If group participants agree, I suggest that we reverse the order of the
> comments, and do not have to necessarily divide the time equally .. We have
> already spoken for the whole session today, and I would like to see us
> favoring community input during this session .. That said, in order to
> secure enough time for community feedback during this session​, I propose
> we start each block by listening to community interventions, then respond
> or comment as apporiate ..
>
>
> Thoughts?
>
>
> Kind Regards
>
> --Manal
>
>
> ________________________________
> From: gnso-gac-closed-generics
> <gnso-gac-closed-generics-bounces at icann.org>
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Jeff Neuman
> <jeff at jjnsolutions.com> <jeff at jjnsolutions.com>
> Sent: Monday, June 12, 2023 10:06 PM
> To: Mary Wong; gnso-gac-closed-generics at icann.org
> Subject: Re: [gnso-gac-closed-generics] Outline of next steps and proposed
> agenda for Tuesday session at ICANN77
>
> Mary,
>
> I guess I agree on agenda. The rest of the email on what happens next is
> beyond scope of group.
>
> Get Outlook for iOS<https://aka.ms/o0ukef>
> ________________________________
> From: gnso-gac-closed-generics
> <gnso-gac-closed-generics-bounces at icann.org>
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Mary Wong
> <mary.wong at icann.org> <mary.wong at icann.org>
> Sent: Monday, June 12, 2023 2:02:48 PM
> To: gnso-gac-closed-generics at icann.org
> <gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org>
> Subject: [gnso-gac-closed-generics] Outline of next steps and proposed
> agenda for Tuesday session at ICANN77
>
>
> Dear all,
>
>
>
> Based on the questions and discussions at the first open session held
> earlier today, and to prepare for the second open session coming up
> tomorrow, staff would like to outline what we understand to be the next
> steps for the dialogue work leading up to a Final Framework. We have
> started to document next steps on your public wiki space<
> https://community.icann.org/display/GFDOCG/FOR+INPUT%3A+Draft+Framework+for+Closed+Generic+gTLDs>,
> and we plan on including this information in the twice-weekly Community
> Leadership Digest that the Policy Development Support team publishes for
> the community, up to the suggested closing date of 15 July 2023. We will
> also coordinate with our colleagues that support all the different SOAC
> groups, to ensure that their members are aware of the invitation to provide
> feedback on the Draft Framework.
>
>
>
> We have set up an email address where community groups and individuals can
> send in their input directly: closed-generics-feedback at icann.org
> <mailto:closed-generics-feedback at icann.org>
> <closed-generics-feedback at icann.org>. This is a publicly-archived<
> https://mm.icann.org/pipermail/closed-generics-feedback/> mailing list,
> which means that you and anyone that wishes to can see the submissions as
> they come in, in full. The staff team will ensure that all submissions are
> made public via the wiki and, similar to the support we provide to other
> community policy-related efforts, collate the feedback into a single tool
> to facilitate your discussions on the input received.
>
>
>
> In addition, and to encourage community groups to submit input, they may
> send their feedback through their staff support team.
>
>
>
> As these steps mirror those that we follow for more formal Public Comment
> proceedings, we hope that this approach, which also ensures that all
> feedback is documented and made public, addresses any concerns from
> community members about transparency, accessibility and their ability to
> provide feedback on the Draft Framework.
>
>
>
> After your deliberations on a Final Framework following your review of the
> community input, our understanding is that the three groups that are
> participating in the dialogue (i.e. the ALAC, GAC and GNSO Council) will
> each use their own internal processes to signal whether they agree with the
> proposed approach in the Final Framework. This is expected to take place in
> the third quarter of this calendar year, and will be the final step before
> moving ahead with the requisite policy work through a GNSO
> Council-chartered process in which the ALAC and GAC will also be involved.
> Of course, as noted in the Draft Framework, if the group does not reach
> agreement on a Final Framework, the issue of closed generic gTLDs will
> revert to the ICANN Board for a decision on the matter for the next round.
>
>
>
> Finally, please find below the proposed agenda for the open session
> tomorrow:
>
>
>
>   1.  Review of the Draft Framework - Melissa Peters Allgood & Dialogue
> Participants (80 mins)
>
> (i)                  Application  (30 mins)
>
>                                 Participant comments  (15 mins)
>
>                                 Community Q&A  (15 mins)
>
> (ii)                Evaluation  (30 mins)
>
>                                 Participant comments  (15 mins)
>
>                                 Community Q&A  (15 mins)
>
> (iii)               Contracting & Post-Delegation  (20 mins)
>
>                                 Participant comments  (10 mins)
>
> Community Q&A  (10 mins)
>
>
>
>   1.  Next Steps - Melissa Peters Allgood (5 mins)
>
>
>
> Best regards,
>
>
>
> Mary (on behalf of Melissa Peters Allgood and the staff team supporting
> the facilitated dialogue) _______________________________________________
> gnso-gac-closed-generics mailing list
> gnso-gac-closed-generics at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your
> personal data for purposes of subscribing to this mailing list accordance
> with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and
> the website Terms of Service (https://www.icann.org/privacy/tos). You can
> visit the Mailman link above to change your membership status or
> configuration, including unsubscribing, setting digest-style delivery or
> disabling delivery altogether (e.g., for a vacation), and so on.
> ________________________________
>  The contents of this email and any attachments are confidential to the
> intended recipient. They may not be disclosed, used by or copied in any way
> by anyone other than the intended recipient. If you have received this
> message in error, please return it to the sender (deleting the body of the
> email and attachments in your reply) and immediately and permanently delete
> it. Please note that Com Laude Group Limited (the “Com Laude Group”) does
> not accept any responsibility for viruses and it is your responsibility to
> scan or otherwise check this email and any attachments. The Com Laude Group
> does not accept liability for statements which are clearly the sender's own
> and not made on behalf of the group or one of its member entities. The Com
> Laude Group is a limited company registered in England and Wales with
> company number 10689074 and registered office at 28-30 Little Russell
> Street, London, WC1A 2HN England. The Com Laude Group includes Nom-IQ
> Limited t/a Com Laude, a company registered in England and Wales with
> company number 5047655 and registered office at 28-30 Little Russell
> Street, London, WC1A 2HN England; Valideus Limited, a company registered in
> England and Wales with company number 6181291 and registered office at
> 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a
> company registered in Scotland with company number SC197176 and registered
> office at 15 William Street, South West Lane, Edinburgh, EH3 7LL Scotland;
> Consonum, Inc. dba Com Laude USA and Valideus USA, a corporation
> incorporated in the State of Washington and principal office address at
> Suite 332, Securities Building, 1904 Third Ave, Seattle, WA 98101; Com
> Laude (Japan) Corporation, a company registered in Japan with company
> number 0100-01-190853 and registered office at 1-3-21 Shinkawa, Chuo-ku,
> Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a company registered
> in Spain and registered office address at Calle Barcas 2, 2, Valencia,
> 46002, Spain. For further information see
> http://www.comlaude.com/<https://comlaude.com/>
>
> _______________________________________________
> gnso-gac-closed-generics mailing listgnso-gac-closed-generics at icann.orghttps://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and the website Terms of Service (https://www.icann.org/privacy/tos). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.
>
> _______________________________________________
> gnso-gac-closed-generics mailing list
> gnso-gac-closed-generics at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your
> personal data for purposes of subscribing to this mailing list accordance
> with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and
> the website Terms of Service (https://www.icann.org/privacy/tos). You can
> visit the Mailman link above to change your membership status or
> configuration, including unsubscribing, setting digest-style delivery or
> disabling delivery altogether (e.g., for a vacation), and so on.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230612/bf824ffc/attachment-0001.html>

More information about the gnso-gac-closed-generics mailing list